相关实验视频
Updated: May 30, 2025
08:56
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
819
用小分子疗法准Wnt信号通路用于治疗骨质疏松症
Shakir Ahamad1, Mohammad Saquib2, Mohd Kamil Hussain3
1Department of Chemistry, Aligarh Muslim University Aligarh 202002 India.
Bioorganic chemistry
|January 26, 2025
概括
小分子通过激活Wnt信号通路来显示骨质疏松症的前景. 然而,临床翻译面临着挑战,需要对其机制和潜在的瘤风险进行进一步研究.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
- 骨生物学 骨生物学 骨生物学
背景情况:
- 骨质疏松症的治疗正在积极寻找新的治疗药物.
- 针对Wnt信号通路的小分子是骨质疏松症治疗的有希望的途径.
- 目前针对骨质疏松症的治疗策略存在局限性,这推动了对新疗法的研究.
研究的目的:
- 审查设计用于激活骨质疏松症治疗Wnt信号的小分子的现有景观.
- 突出开发这些分子用于临床应用的挑战和机遇.
- 强调需要更深入地了解机理学和仔细考虑安全配置文件.
主要方法:
- 对骨质疏松症的Wnt信号激活剂进行的临床前和临床研究的审查.
- 药物设计策略的分析,包括高通量查 (HTS) 和计算机辅助药物设计.
- 检查诸如DKK-1,sclerostin,GSK-3β等分子标及其相互作用.
主要成果:
- 许多小分子正在临床前开发中,针对Wnt途径中的各种点.
- 这些药物的临床前前景和临床进展之间存在很大的差距.
- 高通量选 (HTS) 仍然是主要的发现方法,仅限于使用计算方法.
结论:
- 小分子Wnt激活剂对骨质疏松症具有治疗潜力,但需要进一步的机制研究.
- 必须解决临床转化方面的挑战以及对安全性评估的需求,特别是关于瘤风险的需求.
- 未来的研究应该集中在完善药物设计和阐明机制以优化疗效和安全.
相关概念视频
02:54Canonical Wnt Signaling Pathway
8.7K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.7K
01:41Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
02:33Hedgehog Signaling Pathway
7.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
01:16TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K